Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.45 |
| ▸ | LIPE | Q05469 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | PLAT | P00750 | 1/20 | 0.41 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MGAM | O43451 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | SI | P14410 | 1/20 | 0.40 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ATP4A | P20648 | 1/20 | 0.40 |
| ▸ | ATP4B | P51164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4684239 | 0.91 | MGAM (0.44) | LTA4HMAPK14LIPEL3MBTL1MAPT | |
| SCHEMBL5583748 | 0.91 | KDM4E (0.49) | L3MBTL1LMNAMGAMGAASI | |
| SCHEMBL4159575 | 0.90 | ABCB1 (0.51) | LTA4HABCB1HTR1AKMT2A | |
| Hydrochloric Acid SCHEMBL10371618 | 0.89 | KDM4E (0.51) | L3MBTL1LMNAMGAMGAASI | |
| SCHEMBL16740341 | 0.85 | HTR1A (0.36) | LIPEL3MBTL1PTK2BLMNAMGAM | |
| SCHEMBL4360270 | 0.84 | KMT2A (0.42) | LTA4HMAPK14L3MBTL1MAPTMAPK1 | |
| SCHEMBL10247056 | 0.84 | LMNA (0.47) | LTA4HMAPK14L3MBTL1MAPTMAPK1 | |
| SCHEMBL9654512 | 0.84 | LTA4H (0.45) | LTA4HMAPK14LIPEL3MBTL1MAPT | |
| SCHEMBL10678151 | 0.83 | NPC1 (0.50) | ABCB1HTR1AIDO1 | |
| SCHEMBL10917428 | 0.83 | MAPT (0.57) | LTA4HMAPK14LIPEL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080200520-A1 | Iron Modulators | BTG INTERNATIONAL LIMITED | 2008-08-21 | — | — | US | disclosed |
| US-20070155744-A1 | N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P, ANGELETTI S.P.A. (IT) | 2007-07-05 | — | — | US | disclosed |
| WO-2006103463-A1 | IRON MODULATORS | BTG INTERNATIONAL LIMITED (GB) | 2006-10-05 | — | — | WO | disclosed |
| WO-1992013841-A1 | COMPLEXING AGENTS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-08-20 | — | — | WO | disclosed |
| EP-0498380-A1 | Complexing agents | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-08-12 | — | — | EP | disclosed |
| US-5112968-A | Monobactam hydrazide derivatives | E. R. SQUIBB & SONS, INC. (US) | 1992-05-12 | — | — | US | disclosed |
| EP-0336369-A1 | 3-Acylamino-1-[[[(substituted sulfonyl)amino]carbonyl]amino]2-azetidinones | E.R. Squibb & Sons, Inc. (US) | 1989-10-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200520-A1 | Iron Modulators | SLC40A1, HAMP, FTH1 | LTA4H 1144/4885MAPK14 3550/4885LIPE 2990/4885 |
| US-20070155744-A1 | N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4- carboxamide compounds useful as hiv integrase inhibitors | DUT, NQO2, TYMP | LTA4H 2759/4885MAPK14 3101/4885LIPE 4731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.